Evidera
Sarjil Dwivedi is a Project Manager at Thermo Fisher Scientific since August 2021, bringing extensive experience from previous roles. From January 2014 to July 2021, Sarjil served as Study Director in Bioanalytics and Analytical Services at Lonza. Prior to this, Sarjil worked at COVANCE LABORATORIES LIMITED from May 2007 to January 2014, holding positions such as Study Manager for Biopotency Testing and Experimental Officer Supervisor and Molecular Biology. In these roles, responsibilities included technology transfer, optimization and validation of cell-based assays, and adherence to regulatory standards. Sarjil earned a Master’s degree in Pharmacology and Biotechnology from Sheffield Hallam University in 2007.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.